MCC950 Suppresses Hepatic Inflammaging by Inhibiting NLRP3 Inflammasome Activation in Spontaneously Aged Mice

Key Points

• The research aims to explore how MCC950 can reduce age-related inflammation in the liver by targeting the NLRP3 inflammasome.
• Utilized spontaneously aged mice as a model of hepatic inflammaging.
• Administered MCC950 to inhibit NLRP3 inflammasome activation.
• Evaluated liver inflammation levels post-treatment.
• MCC950 significantly reduced markers of hepatic inflammation.
• Inhibition of the NLRP3 inflammasome correlated with improved liver function.
• Findings indicate a potential therapeutic role for MCC950 in managing liver health in the elderly.